Grove Bank & Trust Has $358,000 Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Grove Bank & Trust decreased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.2% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 686 shares of the medical equipment provider’s stock after selling 38 shares during the period. Grove Bank & Trust’s holdings in Intuitive Surgical were worth $358,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Mirador Capital Partners LP lifted its position in shares of Intuitive Surgical by 1.4% during the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock worth $1,732,000 after buying an additional 50 shares during the period. Exome Asset Management LLC lifted its holdings in Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after buying an additional 1,069 shares in the last quarter. Consolidated Planning Corp boosted its position in Intuitive Surgical by 17.4% in the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after buying an additional 1,198 shares during the last quarter. Wealth Enhancement Advisory Services LLC raised its position in shares of Intuitive Surgical by 73.2% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 270,029 shares of the medical equipment provider’s stock worth $132,657,000 after acquiring an additional 114,149 shares during the last quarter. Finally, Czech National Bank raised its position in shares of Intuitive Surgical by 6.9% during the fourth quarter. Czech National Bank now owns 77,227 shares of the medical equipment provider’s stock worth $40,309,000 after acquiring an additional 4,970 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction dated Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total value of $95,225.76. Following the completion of the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,788,899.12. This trade represents a 3.30 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Jamie Samath sold 22,903 shares of the company’s stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $525.00, for a total value of $12,024,075.00. Following the sale, the insider now owns 8,757 shares in the company, valued at $4,597,425. The trade was a 72.34 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 48,190 shares of company stock worth $25,012,927 over the last ninety days. Insiders own 0.80% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the company. Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their price objective for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. Royal Bank of Canada boosted their price target on shares of Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research note on Friday, October 18th. BTIG Research raised their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research note on Tuesday, November 26th. Stifel Nicolaus upped their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. Finally, The Goldman Sachs Group set a $604.00 price target on Intuitive Surgical in a research report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average target price of $554.17.

Intuitive Surgical Price Performance

ISRG opened at $592.64 on Monday. The company has a market capitalization of $211.09 billion, a price-to-earnings ratio of 95.28, a P/E/G ratio of 4.66 and a beta of 1.39. The business’s 50-day moving average price is $540.66 and its two-hundred day moving average price is $499.19. Intuitive Surgical, Inc. has a 1 year low of $362.14 and a 1 year high of $597.68.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating the consensus estimate of $1.24 by $0.32. The firm had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. Sell-side analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.